blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3724173

EP3724173 - COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  29.07.2022
Database last updated on 19.07.2024
FormerThe patent has been granted
Status updated on  20.08.2021
FormerGrant of patent is intended
Status updated on  08.04.2021
FormerRequest for examination was made
Status updated on  18.09.2020
FormerThe international publication has been made
Status updated on  21.06.2019
Formerunknown
Status updated on  24.12.2018
Most recent event   Tooltip03.05.2024Lapse of the patent in a contracting state
New state(s): MK		published on 05.06.2024  [2024/23]
Applicant(s)For all designated states
NMD Pharma A/S
Palle Juul-Jensens Boulevard 82
8200 Århus N / DK
[N/P]
Former [2021/08]For all designated states
NMD Pharma A/S
Palle Juul-Jensens Boulevard 82
8200 Aarhus N / DK
Former [2020/43]For all designated states
NMD Pharma A/S
c/o Capnova A/S
Åbogade 15
8200 Aarhus N / DK
Inventor(s)01 / J.S. KNUTSEN, Lars
10, Queens House The Esplanade
Frinton-on-Sea, Essex CO13 9AY / GB
02 / KELLY, Nicholas
Højgårds Vænge 32
2880 Bagsværd / DK
03 / HOLM PEDERSEN, Thomas
Sejrs Allé 4A
8240 Risskov / DK
04 / E COOPER, Martin
4 Greenwood Crescent Carlton
Nottingham NG4 1AQ / GB
05 / W. BROWN, Andrew
Chestnut House
Brook Street
Heage, Derbyshire DE56 2AG / GB
 [2020/43]
Representative(s)Høiberg P/S
Adelgade 12
1304 Copenhagen K / DK
[2020/43]
Application number, filing date18819107.614.12.2018
[2020/43]
WO2018EP84989
Priority number, dateUS20171584282314.12.2017         Original published format: US201715842823
EP2017020737514.12.2017         Original published format: EP 17207375
[2020/43]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019115781
Date:20.06.2019
Language:EN
[2019/25]
Type: A1 Application with search report 
No.:EP3724173
Date:21.10.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 20.06.2019 takes the place of the publication of the European patent application.
[2020/43]
Type: B1 Patent specification 
No.:EP3724173
Date:22.09.2021
Language:EN
[2021/38]
Search report(s)International search report - published on:EP20.06.2019
ClassificationIPC:C07D317/18, C07D233/56, C07D261/08, C07D261/20, C07D271/06, C07D277/22, C07D277/66, C07D213/04, A61K31/357, A61K31/381, A61K31/415, A61K31/4164, A61K31/423, A61K31/4245, A61K31/426, A61K31/428, A61K31/4402, C07D213/12, C07D333/06, C07D271/10, A61P21/00
[2020/43]
CPC:
A61K31/357 (EP,IL); C07D261/08 (IL,KR); A61K31/381 (EP,IL);
A61K31/415 (EP,IL); A61K31/4164 (EP,IL,KR); A61K31/42 (KR);
A61K31/423 (EP,IL); A61K31/4245 (EP,IL); A61K31/426 (EP,IL);
A61K31/428 (EP,IL,KR); A61K31/4402 (EP,IL,KR); A61P21/00 (KR);
A61P25/00 (KR); C07D213/30 (EP,IL,KR); C07D231/12 (IL);
C07D233/60 (EP,IL,KR); C07D261/04 (EP,IL,KR); C07D261/20 (IL);
C07D263/32 (EP,IL,KR); C07D271/06 (IL); C07D271/10 (IL);
C07D277/24 (EP,IL,KR); C07D277/66 (IL); C07D285/06 (EP,IL,KR);
C07D285/12 (EP,IL,KR); C07D307/12 (EP,IL,KR); C07D307/42 (EP,IL,KR);
C07D333/16 (EP,IL,KR) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/43]
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:VERBINDUNGEN ZUR BEHANDLUNG NEUROMUSKULÄRER ERKRANKUNGEN[2020/43]
English:COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS[2020/43]
French:COMPOSES POUR LE TRAITEMENT DE TROUBLES NEUROMUSCULAIRES[2021/15]
Former [2020/43]COMPOSÉS DESTINÉS AU TRAITEMENT DE TROUBLES NEUROMUSCULAIRES
Entry into regional phase13.07.2020National basic fee paid 
13.07.2020Designation fee(s) paid 
13.07.2020Examination fee paid 
Examination procedure30.09.2019Request for preliminary examination filed
International Preliminary Examining Authority: EP
13.07.2020Examination requested  [2020/43]
13.07.2020Date on which the examining division has become responsible
09.04.2021Communication of intention to grant the patent
13.08.2021Fee for grant paid
13.08.2021Fee for publishing/printing paid
13.08.2021Receipt of the translation of the claim(s)
Opposition(s)23.06.2022No opposition filed within time limit [2022/35]
Fees paidRenewal fee
09.12.2020Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU14.12.2018
AL22.09.2021
CY22.09.2021
HR22.09.2021
MC22.09.2021
MK22.09.2021
RO22.09.2021
RS22.09.2021
SK22.09.2021
SM22.09.2021
LU14.12.2021
BG22.12.2021
IS22.01.2022
[2024/23]
Former [2023/33]HU14.12.2018
AL22.09.2021
CY22.09.2021
HR22.09.2021
MC22.09.2021
RO22.09.2021
RS22.09.2021
SK22.09.2021
SM22.09.2021
LU14.12.2021
BG22.12.2021
IS22.01.2022
Former [2023/30]AL22.09.2021
CY22.09.2021
HR22.09.2021
MC22.09.2021
RO22.09.2021
RS22.09.2021
SK22.09.2021
LU14.12.2021
BG22.12.2021
IS22.01.2022
Former [2022/46]AL22.09.2021
HR22.09.2021
MC22.09.2021
RO22.09.2021
RS22.09.2021
SK22.09.2021
LU14.12.2021
BG22.12.2021
IS22.01.2022
Former [2022/33]AL22.09.2021
HR22.09.2021
MC22.09.2021
RO22.09.2021
RS22.09.2021
SK22.09.2021
BG22.12.2021
IS22.01.2022
Former [2022/29]AL22.09.2021
HR22.09.2021
RO22.09.2021
RS22.09.2021
SK22.09.2021
BG22.12.2021
IS22.01.2022
Former [2022/24]HR22.09.2021
RO22.09.2021
RS22.09.2021
SK22.09.2021
BG22.12.2021
IS22.01.2022
Former [2022/10]HR22.09.2021
RS22.09.2021
BG22.12.2021
Former [2022/09]RS22.09.2021
BG22.12.2021
Cited inInternational search[A]FR1451171  (JACQUES LOGEAIS SOC D EXPL DES);
 [A]FR2551063  (INST NAT SANTE RECH MED [FR]);
 [X]WO2004089885  (ASTRAZENECA AB [SE], et al);
 [A]WO2004094386  (LILLY CO ELI [US], et al);
 [XD]WO2006037982  (ASTRAZENECA AB [SE], et al);
 [A]WO2007062773  (7TM PHARMA AS [DK], et al);
 [A]WO2012004722  (ACTELION PHARMACEUTICALS LTD [CH], et al);
 [A]US2013261101  (COMBS ANDREW P [US], et al);
by applicantFR1451171
 WO2004089885
 WO2005105727
 WO2006037982
 US2006211765
 WO2016202341
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.